Management of Treatment-Experienced Patients With HIV

  • Author: Eric S. Daar, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/13/21 (What's New)

Summary

  • Few data are available on the optimal management of virologic failure with a first-line boosted PI regimen
  • A systematic review of multiple randomized, controlled trials of virologic failure with first-line boosted PI–based regimens showed that reinforced adherence and maintenance of the original regimen was as likely to result in virologic suppression as a modification in therapy[Zheng 2014]

Action required